Experience
Finnegan achieves victory for Syneron in cellulite patent suit
Syneron Medical Ltd.
Viora Ltd.
Finnegan successfully represented client Syneron Medical Ltd. against Viora Ltd. and Viora Inc. in a patent infringement action in the E.D. Texas. A year after the suit was initiated and just a few months away from a trial, Viora acknowledged the validity of Syneron’s patent and agreed that for the next 12 years, it will pay Syneron royalties of 7.5% to 15%, depending on the number of U.S. sales of Viora systems that apply vacuum together with radio frequency energy for body contouring, cellulite reduction, skin tightening, and circumferential reduction.
Syneron Medical Ltd. v. Viora Ltd., 2:14-cv-00639, E.D. Tex., Judge Gilstrap
